Patents by Inventor Patrick M.A. Sleiman

Patrick M.A. Sleiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IDENTIFICATION OF NOVEL LOCI IN ASTHMA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF ASTHMA
    Publication number: 20190153523
    Abstract: Compositions for the diagnosis and treatment of asthma are disclosed.
    Type: Application
    Filed: July 21, 2017
    Publication date: May 23, 2019
    Inventors: Hakon Hakonarson, Berta Almogurea, Lyam M. Vasquex, Patrick M.a. Sleiman
  • Asthma susceptibility loci located at chromosome 1q31 for use in diagnostic and therapeutic methods
    Patent number: 9790550
    Abstract: Methods and composition are provided for diagnosing pediat?c onset asthma based on the single nucleotide polymorphism on chromosome 1q31 wherein said single nucleotide polymorphism is set forth in Table 2 or Table 6 of the instant invention Method and composition are also provided for treating and preventing asthma or other inflammatory conditions in a patient in need thereof comp?sing administering an effective amount of an at least one inhibitor which reduces the expression of DENND1 B gene product.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: October 17, 2017
    Assignee: The Children's Hospital of Philadelphia
    Inventors: Hakon Hakonarson, Patrick M. A. Sleiman
  • Asthma Susceptibility Loci Located at Chromosome 1q31 for Use in Diagnostic and Therapeutic Methods
    Publication number: 20110200583
    Abstract: Methods and composition are provided for diagnosing pediat?c onset asthma based on the single nucleotide polymorphism on chromosome 1q31 wherein said single nucleotide polymorphism is set forth in Table 2 or Table 6 of the instant invention Method and composition are also provided for treating and preventing asthma or other inflammatory conditions in a patient in need thereof comp?sing administering an effective amount of an at least one inhibitor which reduces the expression of DENND1 B gene product.
    Type: Application
    Filed: May 18, 2009
    Publication date: August 18, 2011
    Inventors: Hakon Hakonarson, Patrick M.A. Sleiman